The Metabolic Syndrome: A Cancer Risk Factor?
Ayça Nur Demir1, Kerem Can Tunç1, Mehtap Odabaşı2, Oytun Erbaş1
1ERBAS Institute of Experimental Medicine, Illinois, USA & Gebze, Türkiye
2Republic Of Türkiye Ministry of Agriculture And Forestry, İstanbul Food Control Laboratory Directorate, İstanbul, Türkiye
Keywords: Abdominal obesity, cancer, high blood pressure, hyperglycemia, hypertriglyceridemia, metabolic syndrome
Abstract
Metabolic syndrome (MetS) is characterized by diabetes, high blood pressure, hypertriglyceridemia, abdominal obesity, and a decrease in high-density lipoprotein cholesterol levels. Five components cause serious morbidity and mortality in the process of progression in the living body. In addition, it is stated that they are included in the relationship between MetS and cancer in the studies conducted. In this review article, we discussed the link between MetS and cancer and the effects of components on cancer types.
Cite this article as: Demir AN, Tunç KC, Odabaşı M, Erbaş O. The Metabolic Syndrome: A Cancer Risk Factor? JEB Med Sci 2023;4(1):12-20.
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
The authors received no financial support for the research and/or authorship of this article.